AnalystsAlethia YoungAlethia Young's Stock Forecasts
AnalystsAlethia Young
Analyst Ranking
Top 1%
#15 out of 4046 analysts
Average Return
+34.38%
Win Rate
53%44 out of 83
Risk vs Reward
Poor
Good
Alethia Young's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Pacific Biosciences Of California IncPACB | +781.46% | $3.56 | $31.38 | 2020-03-08 - 2021-03-09 | Strong Buy |
Curis IncCRIS | +479.03% | $1.24 | $7.18 | 2020-07-16 - 2021-07-16 | Strong Buy |
Anaptysbio IncANAB | +260.34% | $23.85 | $85.94 | 2017-08-24 - 2018-08-24 | Buy |
Sarepta Therapeutics IncSRPT | +214.48% | $45.38 | $142.71 | 2017-09-06 - 2018-09-07 | Buy |
Ra Pharmaceuticals IncRARX | +206.85% | $10.07 | $30.90 | 2018-08-06 - 2019-08-07 | Buy |
Alethia Young's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Arena Pharmaceuticals IncARNA | 5 | Hold | $100.00 | +0.01% | Downgrades | 9 months ago |
Theseus Pharmaceuticals IncTHRX | 1 | Strong Buy | $25.00 | +331.03% | Initiates Coverage On | a year ago |
Biogen IncBIIB | 4 | Hold | $327.00 | +22.47% | Maintains | a year ago |
Adverum Biotechnologies IncADVM | 2 | Hold | $3.00 | N/A | Downgrades | a year ago |
Rapt Therapeutics IncRAPT | 1 | Strong Buy | $71.00 | N/A | Maintains | a year ago |
Vertex Pharmaceuticals IncVRTX | 3 | Strong Buy | $281.00 | N/A | Maintains | a year ago |
Provention Bio IncPRVB | 2 | Strong Buy | $25.00 | N/A | Maintains | a year ago |
Longboard Pharmaceuticals IncLBPH | 1 | Strong Buy | $32.00 | N/A | Initiates Coverage On | a year ago |
Eledon Pharmaceuticals IncELDN | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 2 years ago |
Neximmune IncNEXI | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 2 years ago |
Akebia Therapeutics IncAKBA | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | 2 years ago |
Fate Therapeutics IncFATE | 1 | Strong Buy | $98.00 | N/A | Maintains | 2 years ago |
Regeneron Pharmaceuticals IncREGN | 2 | Strong Buy | $656.00 | N/A | Maintains | 2 years ago |
Amgen IncAMGN | 6 | Strong Buy | $295.00 | N/A | Maintains | 2 years ago |
Bicycle Therapeutics PLCBCYC | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 2 years ago |
Gilead Sciences IncGILD | 2 | Strong Buy | $84.00 | N/A | Maintains | 2 years ago |
Alx Oncology Holdings IncALXO | 1 | Strong Buy | $64.00 | N/A | Initiates Coverage On | 2 years ago |
Curis IncCRIS | 1 | Strong Buy | $4.00 | N/A | Initiates Coverage On | 2 years ago |
Intercept Pharmaceuticals IncICPT | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Tg Therapeutics IncTGTX | 1 | Strong Buy | $35.00 | N/A | Maintains | 2 years ago |
Marinus Pharmaceuticals IncMRNS | 1 | Strong Buy | $6.00 | N/A | Reiterates | 2 years ago |
Stemline Therapeutics IncSTML | 2 | Hold | $12.50 | N/A | Downgrades | 2 years ago |
Ascendis Pharma AASND | 5 | Strong Buy | $201.00 | N/A | Reiterates | 2 years ago |
Arrowhead Pharmaceuticals IncARWR | 2 | Strong Buy | $60.00 | N/A | Upgrades | 2 years ago |
Ptc Therapeutics IncPTCT | 3 | Strong Buy | $85.00 | N/A | Reiterates | 2 years ago |
Arcus Biosciences IncRCUS | 1 | Strong Buy | $21.00 | N/A | Initiates Coverage On | 2 years ago |
Pacific Biosciences Of California IncPACB | 1 | Strong Buy | $5.00 | N/A | Assumes | 3 years ago |
Aurinia Pharmaceuticals IncAUPH | 1 | Strong Buy | $32.00 | N/A | Maintains | 3 years ago |
Verastem IncVSTM | 1 | Strong Buy | $6.00 | N/A | Maintains | 3 years ago |
Sarepta Therapeutics IncSRPT | 6 | Strong Buy | $217.00 | N/A | Reiterates | 3 years ago |
Agios Pharmaceuticals IncAGIO | 4 | Strong Buy | $70.00 | N/A | Reiterates | 3 years ago |
Incyte CorpINCY | 2 | Hold | $65.00 | N/A | Maintains | 3 years ago |
Spectrum Pharmaceuticals IncSPPI | 1 | Hold | $4.00 | N/A | Downgrades | 3 years ago |
Ra Pharmaceuticals IncRARX | 3 | Buy | $17.00 | N/A | Maintains | 4 years ago |
Anaptysbio IncANAB | 2 | Buy | $104.00 | N/A | Initiates Coverage On | 4 years ago |
Alexion Pharmaceuticals IncALXN | 3 | Buy | $154.00 | N/A | Maintains | 4 years ago |
Tesaro IncTSRO | 3 | Buy | $128.00 | N/A | Maintains | 4 years ago |
Mesoblast LtdMESO | 1 | Sell | N/A | N/A | Downgrades | 5 years ago |
Alnylam Pharmaceuticals IncALNY | 3 | Buy | $154.00 | N/A | Maintains | 5 years ago |
Biomarin Pharmaceutical IncBMRN | 2 | Buy | $116.00 | N/A | Maintains | 5 years ago |
Celgene CorpCELG | 1 | Buy | $129.00 | N/A | Maintains | 5 years ago |
Amerisourcebergen CorpABC | 1 | Buy | $112.00 | N/A | Maintains | 5 years ago |
Puma Biotechnology IncPBYI | 4 | Buy | $106.00 | N/A | Maintains | 5 years ago |
Bioverativ IncBIVV | 3 | Hold | $105.00 | N/A | Maintains | 5 years ago |
Acceleron Pharma IncXLRN | 1 | Buy | $51.00 | N/A | Maintains | 5 years ago |
Intellia Therapeutics IncNTLA | 1 | Buy | $28.00 | N/A | Maintains | 5 years ago |
Darden Restaurants IncDRI | 1 | Hold | $82.00 | N/A | Maintains | 5 years ago |
United Therapeutics CorpUTHR | 1 | Sell | N/A | N/A | Initiates Coverage On | 6 years ago |
©2022 WallStreetZen
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.